To include your compound in the COVID-19 Resource Center, submit it here.

RX-3117: Phase Ib data

Data from 41 patients with solid tumors in the Phase Ib portion of an open-label, dose-escalation, U.S. Phase Ib/IIa trial

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE